Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Anti-EGFR antibody with ADCC-inducing activity

Oct. 31, 2003

Favrille raises financing to support phase II and III trials of FavId for NHL

Oct. 21, 2003

ACP-2127 advanced into preclinical testing

Oct. 20, 2003

Signal patent describes novel ER modulators for osteoporosis, cancer, etc.

Oct. 16, 2003

Evidence of antitumor activity for Xcellerated T-cells and IL-2 in renal cell carcinoma

Oct. 9, 2003

NeuTec seeks development partners for Mycograb for cancer

Oct. 8, 2003

Expansion of phase III Virulizin trial

Oct. 2, 2003

Telomerase-targeting vaccines in development at GemVax

Oct. 1, 2003

Maxim completes enrollment for phase III trial of Ceplene with IL-2

Sep. 29, 2003

Evaluation of a novel antiestrogen drug delivery system

Sep. 29, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...